Drug related deaths (6%) 5-year survival (3%) Cause-specific mortality (3%) 1-year survival (2%) Treatment mortality/morbidity (2%) Perioperative morbidity (1%)
Recurrence/relapse ()
Local recurrence rate (38%) Recurrence rate (overall) (14%)
Relapse (14%) Asymptomatic recurrence (5%) Distant recurrence (5%) Remission (5%) Symptom-free period (5%) Systemic recurrence (5%) Time to recurrence (5%) Time to relapse (5%)
QoL ()
Health-related QoL (8%)
QoL (92%)
Review papers may include more than one endpoint category.
bIncluded review papers of clinical trials that did not consistently report whether the articles they referenced used median or mean OS. When mentioned, the majority of included trial review papers referred to median OS.